Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil add-on therapy in carbamazepine-resistant epilepsy
NL-OMON36793Not yet recruiting
- Sponsor
- SEIN
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of verapamil in epilepsy, sponsored by SEIN. Primary endpoint: Primary efficacy endpoint. Planned start Dec 2010; status: not yet recruiting.
02
Drugs
verapamil
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON36793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36793.